Finance

Lists
Why is 69C down 3.73%?
Dive Deeper
69C:FRA
Tvardi Therapeutics Inc
€0.78
-3.73%
(-0.030) 1D
Oct 19, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 69C...
Open
€0.76
High
€0.78
Low
€0.76
Mkt. cap
12.94M
Avg. vol.
27.00
Volume
0.00
52-wk high
€5.05
52-wk low
€0.74
No. of employees
12
Open
€0.76
High
€0.78
Low
€0.76
Mkt. cap
12.94M
Avg. vol.
27.00
Volume
0.00
52-wk high
€5.05
52-wk low
€0.74
No. of employees
12
News stories
From web sources and news partners
About Tvardi Therapeutics Inc
CEO-
Employees12
Founded2017
HeadquartersSugar Land, Texas, United States
SectorPharmaceutical industry
Websitetvarditherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.60M
5.49M
4.91M
4.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.34M
2.10M
2.14M
2.63M
Operating expense
5.94M
7.59M
7.05M
6.63M
Total operating expenses
5.94M
7.59M
7.05M
6.63M
Operating income
-5.94M
-7.59M
-7.05M
-6.63M
Other non operating income
-
-
-
-
EBT including unusual items
-5.53M
-7.28M
-6.80M
-6.46M
EBT excluding unusual items
-5.53M
-7.28M
-6.80M
-6.46M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.53M
-7.28M
-6.80M
-6.46M
Net profit margin
-
-
-
-
Earnings per share
-0.59
-0.78
-0.73
-0.69
Interest and investment income
411.00K
312.00K
247.00K
172.00K
Interest expense
-
-
-
-
Net interest expenses
411.00K
312.00K
247.00K
172.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.91M
-7.56M
-7.03M
-6.61M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps